{"transactions":[{"id":1475395,"issuer":{"id":8499,"kind":"organization","name":"Transcode Therapeutics, Inc.","symbol":"RNAZ"},"owners":[{"id":89776,"kind":"person","name":"Calais Philippe","position":1,"cik":"0001693728","reported_name":"Calais Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-18T16:15:39.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the shares subject to this option vested and became exercisable on January 1, 2024, with the remainder vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":70000,"derivative":{"exercise_price":1.2,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001104659-24-072817","document":"tm2417512-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693728/000110465924072817/tm2417512-1_4seq1.xml","form_type":"4"}},{"id":1884691,"issuer":{"id":8499,"kind":"organization","name":"Transcode Therapeutics, Inc.","symbol":"RNAZ"},"owners":[{"id":89776,"kind":"person","name":"Calais Philippe","position":1,"cik":"0001693728","reported_name":"Calais Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-19T20:06:16.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full on December 31, 2023, subject to the Reporting Person's continued service at such time."}],"balance_after":45000,"derivative":{"exercise_price":0.2834,"expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001104659-23-062812","document":"tm2316383-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693728/000110465923062812/tm2316383-1_4seq1.xml","form_type":"4"}},{"id":1898183,"issuer":{"id":8499,"kind":"organization","name":"Transcode Therapeutics, Inc.","symbol":"RNAZ"},"owners":[{"id":89776,"kind":"person","name":"Calais Philippe","position":1,"cik":"0001693728","reported_name":"Calais Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-10T18:10:57.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) May 10, 2024 and (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":9500,"derivative":{"exercise_price":0.2985,"expiration_date":"2033-05-09","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001104659-23-058580","document":"tm2315294-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693728/000110465923058580/tm2315294-1_4seq1.xml","form_type":"4"}},{"id":2224179,"issuer":{"id":8499,"kind":"organization","name":"Transcode Therapeutics, Inc.","symbol":"RNAZ"},"owners":[{"id":89776,"kind":"person","name":"Calais Philippe","position":1,"cik":"0001693728","reported_name":"Calais Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-22T20:27:17.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 22, 2023 and (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time."}],"balance_after":9500,"derivative":{"exercise_price":1.24,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001104659-22-073636","document":"tm2219203d3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693728/000110465922073636/tm2219203d3_4seq1.xml","form_type":"4"}},{"id":3502571,"issuer":{"id":124935,"kind":"organization","name":"CohBar, Inc.","symbol":"CWBR"},"owners":[{"id":89776,"kind":"person","name":"Calais Philippe","position":1,"cik":"0001693728","reported_name":"Calais Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2019-06-04T08:36:40.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vested immediately upon grant."}],"balance_after":24000,"derivative":{"exercise_price":1.72,"expiration_date":"2029-05-31","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001213900-19-010010","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693728/000121390019010010/ownership.xml","form_type":"4"}},{"id":3737765,"issuer":{"id":124935,"kind":"organization","name":"CohBar, Inc.","symbol":"CWBR"},"owners":[{"id":89776,"kind":"person","name":"Calais Philippe","position":1,"cik":"0001693728","reported_name":"Calais Philippe","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Executive Office"}}],"security":"Stock Options (right to buy)","published_at":"2018-12-10T16:14:33.000Z","date":"2018-12-06","kind":"grant","acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option shall vest in 4 successive monthly installments beginning December 7, 2018."}],"balance_after":96000,"derivative":{"exercise_price":3.57,"expiration_date":"2028-12-06","underlying":"Common Stock","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0001209191-18-061737","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693728/000120919118061737/doc4.xml","form_type":"4"}},{"id":3901774,"issuer":{"id":124935,"kind":"organization","name":"CohBar, Inc.","symbol":"CWBR"},"owners":[{"id":89776,"kind":"person","name":"Calais Philippe","position":1,"cik":"0001693728","reported_name":"Calais Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2018-06-07T18:07:20.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option shall vest in 48 successive monthly installments beginning June 6, 2018."}],"balance_after":200000,"derivative":{"exercise_price":8.86,"expiration_date":"2028-06-06","underlying":"Comon Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-18-036482","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693728/000120919118036482/doc4.xml","form_type":"4"}},{"id":3946463,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":89776,"kind":"person","name":"Calais Philippe","position":1,"cik":"0001693728","reported_name":"Calais Philippe","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Director"}}],"security":"Options to purchase common stock","published_at":"2018-05-04T17:00:26.000Z","date":"2018-05-02","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":80000,"derivative":{"exercise_price":0.98,"exercise_date":"2018-05-02","expiration_date":"2023-05-02","underlying":"common stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-18-006281","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315218006281/form4.xml","form_type":"4"}},{"id":4115588,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":89776,"kind":"person","name":"Calais Philippe","position":1,"cik":"0001693728","reported_name":"Calais Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-01-03T18:41:30.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":3800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 1,900 shares of common stock are exercisable beginning on January 3, 2018, and options to purchase 1,900 shares of common stock are exercisable beginning on January 3, 2019."}],"balance_after":3800,"derivative":{"exercise_price":1.56,"expiration_date":"2023-01-03","underlying":"common stock","underlying_shares":3800},"source":{"system":"sec-edgar","filing":"0001587074-18-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000158707418000002/primary_doc.xml","form_type":"4"}},{"id":4506164,"issuer":{"id":127789,"kind":"organization","name":"Adhera Therapeutics, Inc.","symbol":"ATRX"},"owners":[{"id":89776,"kind":"person","name":"Calais Philippe","position":1,"cik":"0001693728","reported_name":"Calais Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2017-01-04T18:17:54.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase 40,500 shares of common stock are exercisable beginning on January 3, 2017, and options to purchase 40,500 shares of common stock are exercisable beginning on January 3, 2018."}],"balance_after":81000,"derivative":{"exercise_price":0.17,"expiration_date":"2022-01-03","underlying":"common stock","underlying_shares":81000},"source":{"system":"sec-edgar","filing":"0001493152-17-000141","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/737207/000149315217000141/form4.xml","form_type":"4"}}]}